vs
Side-by-side financial comparison of Kennedy-Wilson Holdings, Inc. (KW) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $120.6M, roughly 1.4× Kennedy-Wilson Holdings, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs -82.0%, a 130.1% gap on every dollar of revenue. On growth, Kennedy-Wilson Holdings, Inc. posted the faster year-over-year revenue change (-11.0% vs -22.7%). PTC THERAPEUTICS, INC. produced more free cash flow last quarter ($-36.6M vs $-55.2M). Over the past eight quarters, Kennedy-Wilson Holdings, Inc.'s revenue compounded faster (-6.0% CAGR vs -11.5%).
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
KW vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.6M | $164.7M |
| Net Profit | $58.0M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 57.3% | -43.3% |
| Net Margin | 48.1% | -82.0% |
| Revenue YoY | -11.0% | -22.7% |
| Net Profit YoY | 32.7% | -104.8% |
| EPS (diluted) | $0.22 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.6M | $164.7M | ||
| Q3 25 | $116.4M | $211.0M | ||
| Q2 25 | $135.7M | $178.9M | ||
| Q1 25 | $128.3M | $1.2B | ||
| Q4 24 | $135.5M | $213.2M | ||
| Q3 24 | $127.5M | $196.8M | ||
| Q2 24 | $132.0M | $186.7M | ||
| Q1 24 | $136.4M | $210.1M |
| Q4 25 | $58.0M | $-135.0M | ||
| Q3 25 | $-10.2M | $15.9M | ||
| Q2 25 | $5.6M | $-64.8M | ||
| Q1 25 | $-29.6M | $866.6M | ||
| Q4 24 | $43.7M | $-65.9M | ||
| Q3 24 | $-66.8M | $-106.7M | ||
| Q2 24 | $-48.3M | $-99.2M | ||
| Q1 24 | $37.7M | $-91.6M |
| Q4 25 | 57.3% | -43.3% | ||
| Q3 25 | -6.2% | 1.4% | ||
| Q2 25 | 7.4% | -19.5% | ||
| Q1 25 | -26.9% | 82.5% | ||
| Q4 24 | 36.7% | -76.2% | ||
| Q3 24 | -60.8% | -27.7% | ||
| Q2 24 | -45.5% | -21.5% | ||
| Q1 24 | 47.2% | -21.6% |
| Q4 25 | 48.1% | -82.0% | ||
| Q3 25 | -8.8% | 7.5% | ||
| Q2 25 | 4.1% | -36.3% | ||
| Q1 25 | -23.1% | 73.7% | ||
| Q4 24 | 32.3% | -30.9% | ||
| Q3 24 | -52.4% | -54.2% | ||
| Q2 24 | -36.6% | -53.1% | ||
| Q1 24 | 27.6% | -43.6% |
| Q4 25 | $0.22 | $-1.63 | ||
| Q3 25 | $-0.15 | $0.20 | ||
| Q2 25 | $-0.05 | $-0.83 | ||
| Q1 25 | $-0.30 | $10.04 | ||
| Q4 24 | $0.24 | $-0.85 | ||
| Q3 24 | $-0.56 | $-1.39 | ||
| Q2 24 | $-0.43 | $-1.29 | ||
| Q1 24 | $0.19 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $-205.3M |
| Total Assets | $6.6B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $184.5M | $1.9B | ||
| Q3 25 | $382.6M | $1.7B | ||
| Q2 25 | $309.1M | $2.0B | ||
| Q1 25 | $356.6M | $2.0B | ||
| Q4 24 | $217.5M | $1.1B | ||
| Q3 24 | $367.1M | $1.0B | ||
| Q2 24 | $366.5M | $1.1B | ||
| Q1 24 | $541.9M | $884.8M |
| Q4 25 | $1.5B | $-205.3M | ||
| Q3 25 | $1.5B | $-155.8M | ||
| Q2 25 | $1.6B | $-206.5M | ||
| Q1 25 | $1.6B | $-185.8M | ||
| Q4 24 | $1.6B | $-1.1B | ||
| Q3 24 | $1.6B | $-1.1B | ||
| Q2 24 | $1.7B | $-980.2M | ||
| Q1 24 | $1.7B | $-893.9M |
| Q4 25 | $6.6B | $2.9B | ||
| Q3 25 | $6.7B | $2.6B | ||
| Q2 25 | $6.8B | $2.6B | ||
| Q1 25 | $7.2B | $2.7B | ||
| Q4 24 | $7.0B | $1.7B | ||
| Q3 24 | $7.4B | $1.8B | ||
| Q2 24 | $7.5B | $1.9B | ||
| Q1 24 | $7.7B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $-34.3M |
| Free Cash FlowOCF − Capex | $-55.2M | $-36.6M |
| FCF MarginFCF / Revenue | -45.8% | -22.3% |
| Capex IntensityCapex / Revenue | 55.2% | 1.4% |
| Cash ConversionOCF / Net Profit | 0.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.5M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $-34.3M | ||
| Q3 25 | $-7.6M | $-66.3M | ||
| Q2 25 | $42.0M | $-58.3M | ||
| Q1 25 | $-51.9M | $870.1M | ||
| Q4 24 | $55.1M | $-30.0M | ||
| Q3 24 | $-5.6M | $-77.0M | ||
| Q2 24 | $36.7M | $-71.5M | ||
| Q1 24 | $-5.6M | $70.8M |
| Q4 25 | $-55.2M | $-36.6M | ||
| Q3 25 | $-18.0M | $-69.7M | ||
| Q2 25 | $29.4M | $-59.6M | ||
| Q1 25 | $-59.7M | $868.4M | ||
| Q4 24 | $-76.5M | $-33.8M | ||
| Q3 24 | $-27.7M | $-77.5M | ||
| Q2 24 | $-500.0K | $-78.8M | ||
| Q1 24 | $-57.1M | $61.2M |
| Q4 25 | -45.8% | -22.3% | ||
| Q3 25 | -15.5% | -33.1% | ||
| Q2 25 | 21.7% | -33.3% | ||
| Q1 25 | -46.5% | 73.8% | ||
| Q4 24 | -56.5% | -15.8% | ||
| Q3 24 | -21.7% | -39.4% | ||
| Q2 24 | -0.4% | -42.2% | ||
| Q1 24 | -41.9% | 29.1% |
| Q4 25 | 55.2% | 1.4% | ||
| Q3 25 | 8.9% | 1.6% | ||
| Q2 25 | 9.3% | 0.7% | ||
| Q1 25 | 6.1% | 0.1% | ||
| Q4 24 | 97.1% | 1.8% | ||
| Q3 24 | 17.3% | 0.3% | ||
| Q2 24 | 28.2% | 4.0% | ||
| Q1 24 | 37.8% | 4.6% |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | 7.50× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
PTCT
Segment breakdown not available.
